These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 27364922)
1. Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities. Wong CY; Martinez J; Dass CR J Pharm Pharmacol; 2016 Sep; 68(9):1093-108. PubMed ID: 27364922 [TBL] [Abstract][Full Text] [Related]
2. Oral insulin delivery: existing barriers and current counter-strategies. Gedawy A; Martinez J; Al-Salami H; Dass CR J Pharm Pharmacol; 2018 Feb; 70(2):197-213. PubMed ID: 29193053 [TBL] [Abstract][Full Text] [Related]
3. Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus. Wong CY; Al-Salami H; Dass CR Int J Pharm; 2018 Oct; 549(1-2):201-217. PubMed ID: 30071309 [TBL] [Abstract][Full Text] [Related]
4. Oral insulin-delivery system for diabetes mellitus. Kanzarkar M; Pathak PP; Vaidya M; Brumlik C; Choudhury A Pharm Pat Anal; 2015 Jan; 4(1):29-36. PubMed ID: 25565158 [TBL] [Abstract][Full Text] [Related]
5. A review of biodegradable polymeric systems for oral insulin delivery. Luo YY; Xiong XY; Tian Y; Li ZL; Gong YC; Li YP Drug Deliv; 2016 Jul; 23(6):1882-91. PubMed ID: 26066036 [TBL] [Abstract][Full Text] [Related]
6. [Inhaled insulin, new perspective for insulin therapy]. Radermecker RP; Sélam JL Rev Med Liege; 2005; 60(5-6):355-60. PubMed ID: 16035294 [TBL] [Abstract][Full Text] [Related]
7. [Biotechnological and administration innovations in insulin therapy]. Verge D Med Sci (Paris); 2004 Nov; 20(11):986-98. PubMed ID: 15525494 [TBL] [Abstract][Full Text] [Related]
8. Nanotechnology in Insulin Delivery for Management of Diabetes. Bahman F; Greish K; Taurin S Pharm Nanotechnol; 2019; 7(2):113-128. PubMed ID: 30907328 [TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of inhaled insulin. Mastrandrea LD; Quattrin T Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1061-75. PubMed ID: 17070613 [TBL] [Abstract][Full Text] [Related]
10. The physiological rationale for oral insulin administration. Arbit E Diabetes Technol Ther; 2004 Aug; 6(4):510-7. PubMed ID: 15321008 [TBL] [Abstract][Full Text] [Related]
11. Nanoparticle strategies for the oral delivery of insulin. Damgé C; Reis CP; Maincent P Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928 [TBL] [Abstract][Full Text] [Related]
12. A Brief Overview of the Oral Delivery of Insulin as an Alternative to the Parenteral Delivery. Macedo A; Filipe P; Thomé NG; Vieira J; Oliveira C; Teodósio C; Ferreira R; Roque L; Fonte P Curr Mol Med; 2020; 20(2):134-143. PubMed ID: 31965934 [TBL] [Abstract][Full Text] [Related]
13. Oral insulin delivery: how far are we? Fonte P; Araújo F; Reis S; Sarmento B J Diabetes Sci Technol; 2013 Mar; 7(2):520-31. PubMed ID: 23567010 [TBL] [Abstract][Full Text] [Related]
14. Transdermal delivery of antidiabetic drugs: formulation and delivery strategies. Ahad A; Al-Saleh AA; Akhtar N; Al-Mohizea AM; Al-Jenoobi FI Drug Discov Today; 2015 Oct; 20(10):1217-27. PubMed ID: 26100737 [TBL] [Abstract][Full Text] [Related]
16. New strategies to improve the intranasal absorption of insulin. Duan X; Mao S Drug Discov Today; 2010 Jun; 15(11-12):416-27. PubMed ID: 20359545 [TBL] [Abstract][Full Text] [Related]
19. Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin. Wong CY; Al-Salami H; Dass CR Int J Pharm; 2018 Feb; 537(1-2):223-244. PubMed ID: 29288095 [TBL] [Abstract][Full Text] [Related]
20. Transition from passive to active targeting of oral insulin nanomedicines: enhancement in bioavailability and glycemic control in diabetes. Kaklotar D; Agrawal P; Abdulla A; Singh RP; Mehata AK; Singh S; Mishra B; Pandey BL; Trigunayat A; Muthu MS Nanomedicine (Lond); 2016 Jun; 11(11):1465-86. PubMed ID: 27171572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]